Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058624) titled 'Impact of high oxygen concentration on excercise duration in patients with interstitial lung disease following acute exacerbation' on July 29.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Dose comparison
Primary Sponsor:
Institute - Seirei Mikatahara General Hospital, Dept. of Rehabilitation
Condition:
Condition - Interstitial Lung Disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aimed to evaluate whether high-concentration oxygen delivered via HFNC could improve exercise capacity in patients during the recovery phase following AE-ILD.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - High-flow nasal cannula (40L/min, FiO2 60%)
Interventions/Control_2 - High-flow nasal cannula (40L/min, FiO2 21%)
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - acute exacerbation of interstitial lung disease
Key exclusion criteria - Patients who were unable to undergo the constant-load ergometry test (CLET) owing to motor dysfunction, cognitive dysfunction, or other diseases were excluded.
Target Size - 25
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2018 Year 11 Month 30 Day
Date of IRB - 2018 Year 11 Month 30 Day
Anticipated trial start date - 2018 Year 12 Month 01 Day
Last follow-up date - 2019 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066964
Disclaimer: Curated by HT Syndication.
